These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19914881)

  • 1. Role of cardiac computed tomography in planning and evaluating percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Okayama S; Uemura S; Soeda T; Horii M; Saito Y
    J Cardiovasc Comput Tomogr; 2010; 4(1):62-5. PubMed ID: 19914881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
    Kurita T; Tsuchikane E; Tanaka N; Suzuki T
    Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of multi-detector row computed tomography for the management of percutaneous transluminal septal myocardial ablation in patient with hypertrophic obstructive cardiomyopathy.
    Mitsutake R; Miura S; Sako H; Nishikawa H; Saku K
    Int J Cardiol; 2008 Sep; 129(2):e61-3. PubMed ID: 17888532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion.
    Kuhn H; Gietzen FH; Schäfers M; Freick M; Gockel B; Strunk-Müller C; Jachmann E; Schober O
    Eur Heart J; 1999 Dec; 20(24):1808-17. PubMed ID: 10581139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of left ventricular myocardial perfusion and function using gated SPECT in patients with hypertrophic obstruction cardiomyopathy following percutaneous transluminal septal myocardial ablation.
    Zhang L; Liu R; Qiao SB; Sun XX; He ZX; Tian YQ
    Nucl Med Commun; 2014 Jul; 35(7):762-6. PubMed ID: 24681766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful second attempt multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation for an octogenarian with hypertrophic obstructive cardiomyopathy.
    Maekawa Y; Jinzaki M; Anzai A; Tsuruta H; Matsumura K; Yamada Y; Tabei R; Kawakami T; Hayashida K; Yuasa S; Murata M; Suzuki M; Kuribayashi S; Fukuda K
    Int J Cardiol; 2014 Oct; 176(3):e131-2. PubMed ID: 25150473
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging.
    van Dockum WG; ten Cate FJ; ten Berg JM; Beek AM; Twisk JW; Vos J; Hofman MB; Visser CA; van Rossum AC
    J Am Coll Cardiol; 2004 Jan; 43(1):27-34. PubMed ID: 14715178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical case of the month. Treatment of obstructive hypertrophic cardiomyopathy by percutaneous septal ablation].
    Hoffer E; Boland J
    Rev Med Liege; 2002 Jul; 57(7):433-7. PubMed ID: 12233217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved renal function in a patient with hypertrophic obstructive cardiomyopathy after multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation.
    Maekawa Y; Jinzaki M; Tsuruta H; Akita K; Yamada Y; Kawakami T; Hayashida K; Yuasa S; Murata M; Fukuda K
    Int J Cardiol; 2015 Feb; 181():349-50. PubMed ID: 25555276
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocardial perfusion after percutaneous transluminal septal myocardial ablation as assessed by myocardial contrast echocardiography in patients with hypertrophic obstructive cardiomyopathy.
    Pedone C; Biagini E; Galema TW; Vletter WB; ten Cate FJ
    J Am Soc Echocardiogr; 2006 Aug; 19(8):982-6. PubMed ID: 16880092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Percutaneous transluminal septal myocardial ablation in the treatment of hypertrophic obstructive cardiomyopathy: short-term study].
    Veselka J; Tesar D; Urbanová T; Telekes P; Honĕk T; Neuwirth J
    Vnitr Lek; 2001 Jul; 47(7):437-43. PubMed ID: 11505713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy.
    Crossen K; Jones M; Erikson C
    Heart Rhythm; 2016 Sep; 13(9):1885-90. PubMed ID: 27132152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparable effects of percutaneous transluminal septal myocardial ablation and subaortic ventriculotomy in treating patients with hypertrophic obstructive cardiomyopathy, an echocardiography follow-up study].
    Li J; Liu YL; He Q; Qiao SB; Feng W; Lü XZ; Zhu ZH; Ling Y; Wang JP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):695-8. PubMed ID: 17081391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
    Seggewiss H; Faber L
    Eur J Echocardiogr; 2000 Dec; 1(4):277-80. PubMed ID: 11916606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Moving left ventricular obstruction" due to stress cardiomyopathy in a patient with hypertrophic obstructive cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
    Akita K; Maekawa Y; Tsuruta H; Okuda S; Yanagisawa R; Kageyama T; Kawakami T; Kanazawa H; Hayashida K; Yuasa S; Murata M; Jinzaki M; Fukuda K
    Int J Cardiol; 2016 Jan; 202():194-5. PubMed ID: 26397409
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocardial perfusion improvement and mechanism after percutaneous intramyocardial septal radiofrequency ablation in obstructive hypertrophic cardiomyopathy: a study of myocardial contrast echocardiography.
    Yao L; Ta S; Wang J; Han C; Lei C; Li W; Li J; Wang B; Zhao X; Liu L
    Int J Cardiovasc Imaging; 2024 Jul; 40(7):1483-1492. PubMed ID: 38709352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Repeated percutaneous transluminal septal myocardial ablation leads to reduction of left ventricular outflow-tract pressure gradient in hypertrophic obstructive cardiomyopathy: a case report].
    Takeda M; Mori T; Ohashi Y; Ichikawa S; Terashima M; Ejiri J; Awano K
    J Cardiol; 2006 Jun; 47(6):313-21. PubMed ID: 16800375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the reverse wire technique in multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation.
    Maekawa Y; Jinzaki M; Anzai A; Matsumura K; Tsuruta H; Kawakami T; Hayashida K; Yuasa S; Murata M; Suzuki M; Kuribayashi S; Fukuda K
    Int J Cardiol; 2014 May; 173(3):e33-4. PubMed ID: 24708931
    [No Abstract]   [Full Text] [Related]  

  • 19. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
    Seggewiss H; Faber L; Ziemssen P; Gleichmann U
    Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
    Zeng Z; Wang F; Dou X; Zhang S; Pu J
    Int J Cardiol; 2006 Sep; 112(1):80-4. PubMed ID: 16507323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.